Key result
Multi-omics identifies 51 protein-CVD pairs, pinpointing AGER, CCN3, FER, and SPON1 across cardiovascular traits.
Why the study?
Significant residual risk of cardiovascular diseases remains incompletely captured despite advances in traditional risk factors. Integrative omics analysis incorporating cardiovascular magnetic resonance imaging traits could facilitate the discovery of novel therapeutic targets and potentially druggable plasma proteins.
Observational
Yes
Integrative multi-omics and CMR imaging analysis identified and replicated decenas of putatively causal protein-CVD and protein-CMR associations—specifically pinpointing AGER, CCN3, FER, and SPON1—to prioritize novel druggable targets for cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; leaves open the viability of replicated protein targets for cardiovascular drug development.
Despite advances in traditional risk factors for cardiovascular diseases (CVDs), significant residual risk of CVDs remains incompletely captured. Integrative analysis incorporating cardiovascular magnetic resonance imaging (CMR) could facilitate to discover novel therapeutic targets. This study aimed to identify potentially druggable plasma proteins for CVDs by incorporating CMR traits with integrative omics analysis. By integrating protein quantitative trait loci (pQTL) datasets of plasma proteins from Atherosclerosis Risk in Communities (ARIC) study with genome-wide association studies of 19 CVDs and 82 CMR traits, we sequentially used proteome-wide association study (PWAS), Mendelian randomization (MR), and colocalization analysis to identify putatively causal proteins. Replication MR was conducted using deCODE pQTL data, followed by observational association analysis using UK Biobank individual-level data, and multidimensional downstream analyses, as well as phenome-wide MR (Phe-MR). In total, we identified 342 protein–CVD and 115 protein–CMR pairs through PWAS. MR and colocalization analyses revealed 66 protein–CVD and 39 protein–CMR pairs with potential causal relationships, of which 51 protein–CVD and 33 protein–CMR pairs were replicated. Additionally, 26 protein–CVD and 6 protein–CMR pairs showed significantly observational associations. Multidimensional downstream analysis highlighted potential biological pathways and druggability insights. Notably, AGER, CCN3, FER, and SPON1 were identified as proteins associated with both CVDs and CMR traits. Phe-MR analysis suggests potential beneficial and adverse effects of these proteins on other diseases. Our findings highlight potentially druggable plasma proteins for CVDs by incorporating CMR traits, providing novel insights into CVD pathogenesis and therapeutic drug development.
No takes yet. Share an insight, caveat, or question.
Gong et al. (2026) conducted an observational in Cardiovascular diseases (19 CVDs) and cardiovascular magnetic resonance (CMR) traits (82 traits). Genetically predicted and circulating plasma protein levels (1,348 cis-heritable proteins in discovery) was evaluated on Putatively causal and replicated associations between plasma proteins, 19 CVDs, and 82 CMR traits (p=<0.05 (FDR-corrected)). Integrative multi-omics analysis replicated 51 protein-CVD and 33 protein-CMR causal pairs, pinpointing AGER, CCN3, FER, and SPON1 as associated with both CVDs and CMR traits.
Synapse has enriched 10 related papers. Consider them for comparative context: